探讨纤溶酶原激活物抑制因子-1水平对评价2型糖尿病短期强化治疗疗效的临床意义

• Effect of different short-term intensive treatment methods on plasminogen activator inhibitor-1 in newly diagnosed type 2 diabetic patients